The inverse findings of low IFNγ in more severely ill participants is consistent across a number of comparisons, with low IFNy predictive of subsequent therapy non-response, associated cross-sectionally with non-response, negatively correlated with depression severity and particularly the somatic symptoms as well as negative correlations with treatment-resistance severity (MSM score). Here, IFNG is linked to depressive symptom measurement.